Abstract:
Objective To examine the expression of progesterone receptor membrane component-1 (PGRMC1) gene and explore its effect on the evolution of ovarian cancers.
Methods The protein expression of PGRMC1 in various ovarian lesions was detected by immunohistochemistry. TATA box binding protein gene was used as an endogenous control. The mRNA expression of PGRMC1 gene in 10 cases of benign ovarian tumor tissues and 30 cases of epithelial ovarian cancer tissue was quantified by real-time PCR.
Results The expression levels of PGRMC1 protein in borderline ovarian tumor (3.60 ± 1.14) and ovarian cancer (7.30 ± 2.12) tissues were significantly higher than in normal ovarian (0.20 ± 0.71) and benign ovarian tumor (0.75 ± 1.12) tissues (all P < 0.01). Real-time PCR confirmed that the mRNA expression level was significantly different between ovarian cancer (3.526 ± 1.386) and benign ovarian tumor (0.936 ± 0.725) tissues (P < 0.01). The microvessel density in ovarian cancer tissues (28.4 ± 8.1) was significantly higher than in normal ovarian (18.6 ± 6.7) and benign ovarian tumor (20.9 ±7.9) tissues (all P < 0.01).
Conclusion The expression of PGRMC1 gene in ovarian tumor tissues is significantly elevated, which may play an important role in the occurrence, development, and angiogenesis of ovarian cancer.